“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: A-139 COMPARISON OF 4T-SCORE AND LABORATORY TESTS IN THE DIAGNOSIS OF HIT

€3.03

SKU: product-article-18544 Category: General

Description
Reviews (0)

Description

A-139 COMPARISON OF 4T-SCORE AND LABORATORY TESTS IN THE DIAGNOSIS OF HIT

Reviews

There are no reviews yet.

Be the first to review “Article: A-139 COMPARISON OF 4T-SCORE AND LABORATORY TESTS IN THE DIAGNOSIS OF HIT”

You must be logged in to post a review.

Top

Article: A-139 COMPARISON OF 4T-SCORE AND LABORATORY TESTS IN THE DIAGNOSIS OF HIT

Description

Reviews

Related products

1 year access Online Belgian Journal of Hematology (BJH)

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in urologic cancer

Article: Highlights in gynaecological cancers